Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients. [electronic resource]
Producer: 20201015Description: 7526 p. digitalISSN:- 2045-2322
- Adaptive Immunity -- drug effects
- Adult
- CD4-Positive T-Lymphocytes -- drug effects
- Cytokines -- metabolism
- Female
- Healthy Volunteers
- Humans
- Immunologic Factors -- pharmacology
- Immunosuppressive Agents -- pharmacology
- Lymphocyte Activation -- drug effects
- Male
- Methotrexate -- pharmacology
- Middle Aged
- Psoriasis -- drug therapy
- T-Lymphocytes, Regulatory -- drug effects
- Th1 Cells -- drug effects
- Th17 Cells -- drug effects
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.